RATIONALE: Eosinophils are a major leukocyte recruited to the lungs in both mouse allergen provocation models and patients with asthma. However, a link between these cells and the pathological changes occurring in the lung remains obscure although eosinophil effector functions have been hypothesized to be mediated, in part, by the release of secreted cationic proteins sequestered in cytoplasmic granules (i.e., the degranulation of activated eosinophils recruited to the lung).METHODS: Gene knockout lines of mice deficient for the two eosinophil major basic proteins (MBP-1, -2) were generated (strain: 129) by homologous recombination in ES cells and used in an acute allergen sensitization/aerosol challenge protocol to define causative links with pulmonary allergic infammation.RESULTS: This study demonstrates that despite observations showing that allergen challenge mouse models display only nominal levels of eosinophil degranulation the loss of the eosinophil granule protein MBP-2 abolished allergen-induced airway hyperresponsiveness (AHR). The loss of AHR in MBP-2-/- mice occurred with out concominant loss of other allergen-induced pulmonary pathologies (e.g., goblet cell metaplasia), suggesting a specific link between this pathophysiologic response and MBP-2 mediated activities. Interestingly, the MBP-2 associated effects on AHR were specific to this major basic protein isoform as the loss of the more abundant granule protein MBP-1 had no effects on pulmonary pathologies, including AHR.CONCLUSIONS: The identification of a causative link between AHR and the release of an eosinophil secondary granule protein (i.e., degranluation) provides a an important link between allergen-induced pathologies and this long suspected eosinophil-mediated activity in the lung. RATIONALE: Eosinophils are a major leukocyte recruited to the lungs in both mouse allergen provocation models and patients with asthma. However, a link between these cells and the pathological changes occurring in the lung remains obscure although eosinophil effector functions have been hypothesized to be mediated, in part, by the release of secreted cationic proteins sequestered in cytoplasmic granules (i.e., the degranulation of activated eosinophils recruited to the lung). METHODS: Gene knockout lines of mice deficient for the two eosinophil major basic proteins (MBP-1, -2) were generated (strain: 129) by homologous recombination in ES cells and used in an acute allergen sensitization/aerosol challenge protocol to define causative links with pulmonary allergic infammation. RESULTS: This study demonstrates that despite observations showing that allergen challenge mouse models display only nominal levels of eosinophil degranulation the loss of the eosinophil granule protein MBP-2 abolished allergen-induced airway hyperresponsiveness (AHR). The loss of AHR in MBP-2-/- mice occurred with out concominant loss of other allergen-induced pulmonary pathologies (e.g., goblet cell metaplasia), suggesting a specific link between this pathophysiologic response and MBP-2 mediated activities. Interestingly, the MBP-2 associated effects on AHR were specific to this major basic protein isoform as the loss of the more abundant granule protein MBP-1 had no effects on pulmonary pathologies, including AHR. CONCLUSIONS: The identification of a causative link between AHR and the release of an eosinophil secondary granule protein (i.e., degranluation) provides a an important link between allergen-induced pathologies and this long suspected eosinophil-mediated activity in the lung.
Read full abstract